Author Archive for Sue Vogan

Judy Mikovits

 I do apologize for not writing more sooner. As most everyone knows, the 2012 Physician’s Round Table, January 26-28, in Tampa, Florida has been keeping me very busy. More information can be found at

Lately, many have inquired about Judy Mikovits, so I thought it might be a good time to contact her. While she was removed from the 2012 Physician’s Round Table lineup of presenters so that she could more fully concentrate on the current legal situation, she was never far from our thoughts and prayers.

I had an opportunity to catch up with Dr. Mikovits. I asked her how things were.

“I sincerely appreciate the support. I cannot discuss the legal issues as you might expect.

I am committed to moving forward this work and am working as the PI on the Lipkin study according to the original study design and we are confident that no matter what the results with MRVs, this study will move the field forward. We are also working on several initiatives in Canada and have been met with enthusiasm.

My current situation is horrendous and while I can say that I did not expect a bed of roses when I started working in the CFS community, knowing full well how other scientists and physicians have been treated poorly, I did not expect to be jailed. If this can happen to me without any wrongdoing, it can happen to anyone in the field and we all must stick together and make certain that our government knows that neither the patients nor the physicians/scientists find this acceptable.” – Dr. Judy Mikovits, 12/27/11

For those of us who still believe in “innocent until proven guilty,” a legal defense fund has been set up for Dr. Mikovits:

Mikovits Legal Fund 2031 Jamestown Way, Oxnard, CA 93035 or donate online at

and for questions or well wishes, please send to:


New Lab Test

Brand-new test now available for the actual Borrelia activity in the blood:

Borrelia-Elispot-LTT = Lymphocyte Transformation Test

Test-principle: Interferon-Gamma Release Assay (IGRA) by standardized T-SPOT technique

Elispot-LTT now approved by the CDC and FDA for Tuberculosis bacterium!

Same test-principle available for 3 different Borrelia burgdorferi antigens now (Fully antigen, peptide mix and LFA1), LFA1 especially in Rheumatoid Arthritis and Fibromyalgia

 Measurement of Borrelia-Elispot-LTT: Number of IFN-gamma producing cells (spots)

Elispot measures a person’s actual immune reaction against Borrelia burgdorferi

Possible results: positive, negative and borderline

Elispot-LTT for Borrelia test-sensitivity: around 76%

Elispot-LTT cannot exclude a Lyme infection, but is very helpful in diagnosing, if the result is positive!

Elispot-LTT technique is also available for Ehrlichia/Anaplasma and especially Chlamydia pneumoniae and Chlamydia trachomatis!

Most patients with Lyme disease suffer from Chlamydia pneumonia at the same point of time (multiple infections)

Chlamydia pneumoniae is found exactly in the same diseases than Borrelia (“overlapping symptoms”):

Chronic Fatique Syndrom (CFS), Multiple Sclerosis, Parkinsonism, Rheumatoid Arthritis, Fibromyalgia, Arthrosis, Carpal-Tunnel-Syndrome, Arthritis, Alzheimers, Dementia, Persistent Cough (atypical pneumoniae), Autism…..

Therefore you have to test each Lyme patient for Chlamydia pneumoniae with Elispot-LTT!

Why? Because therapists can only do the right antibiotic or other treatment choice, if they know about the bacterial enemies exactly!

Elispot-LTT for Borrelia and Chlamydia is very helpful in controlling, if a therapy was successful, then activity results should be normal after a successful treatment!

Be careful: Use the right tubes for taking blood to stabilize the cells for Elispot-LTT: CPT or CPDA-tubes, all other results from other tubes like Heparin can be false-negative in other laboratories!

What about chronic Lyme activity tests?

CD57-count is very helpful in monitoring chronic Lyme activity, around 70% sensitivity, according Burrascano’s ILADS guidelines.

So you should do Elispot-LTT for Borrelia, Chlamydia and the CD57-count to reach a sensitivity of around 90% in chronic infected patients!

To order your test kit, please contact us at:



2012 Physician’s Round Table

We have selected January 2012 in Florida for the next Physician’s Round Table. If you are interested in presenting, attending or joining us as a vendor, please email us at for more information.

We will be announcing an early bird special soon. It’s never too early to make plans for one of the most informative conferences in the United States.

We look forward to hearing from you!